Glenmark Pharmaceuticals has seen its stock price surge by 97% so far this year, reaching a 52-week high during Friday's trading session. Over the past year, ...

Dr Reddy’s Laboratories: Dr Reddy’s has secured a licensing deal with Ingenus Pharmaceuticals to market Cyclophosphamide injection, used in cancer treatment, ...

In a significant development, Glenmark Pharmaceuticals witnessed a 6% decline in its share price during early trading on September 22. This drop followed the ...

In the dynamic world of financial markets, several key developments have taken place across various sectors. Let's dive into the latest updates:Glenmark ...